4 nominees · 7 ballot items.
Election of four Class 3 directors; non-binding advisory vote on executive compensation (Say-on-Pay); amendment to increase authorized common shares; amendment to authorize uncertificated (book-entry) shares; approval and ratification of the ACNB Corporation Employee Stock Purchase Plan; ratification of Crowe LLP as independent auditor; and transaction of any other properly presented business.
Elect four Class 3 directors (Kimberly S. Chaney, Frank Elsner, III, James P. Helt, and John M. Polli) to serve three-year terms until their successors are elected and qualified.
A non-binding advisory vote to approve the compensation of the Named Executive Officers as disclosed in the proxy statement.
This advisory proposal asks shareholders to approve the compensation paid to ACNB’s Named Executive Officers as disclosed in the proxy materials (the Say-on-Pay vote). Management seeks this annual non-binding endorsement to reaffirm its executive pay philosophy — a program combining base salary, short-term cash incentives (the Variable Compensation Plan), and multi-year restricted equity awards under the Omnibus Stock Incentive Plan — which it says ties pay to adjusted net income, loan growth, ROAE, and strategic objectives. The Compensation Committee sets performance metrics, applies limited one-time adjustments for extraordinary items (e.g., merger expenses or securities restructuring), and retains discretion to apply clawbacks and other safeguards; management emphasizes these features as mitigating excessive risk-taking while aligning management and shareholder interests. The Board recommends a FOR vote, citing the program’s role in retention, succession and execution of the strategic plan (including the Traditions Bancorp acquisition). Critics could note the potential for post-hoc adjustments to performance metrics and the use of discretion in award determinations; however, the proxy discloses historical pay outcomes, benchmarking practices, and a prior strong shareholder approval result (89.15% in 2025), which the Board uses to support continuation of current practices. In evaluating merits, a sophisticated analyst should weigh (i) the clarity and stringency of the performance metrics and vesting schedules; (ii) the magnitude of CEO and NEO pay relative to peer performance and company TSR; (iii) the Committee’s governance mechanisms (independent committee, consultant use, clawbacks); and (iv) how merger-related adjustments and one-time bonuses affect realized pay and incentives. Given ACNB’s narrative that recent discrete merger expenses and securities repositioning were strategic and adjusted for incentive calculations, an analyst should scrutinize whether such adjustments are consistently applied and transparently quantified in future disclosures. Overall, the proposal is procedural (advisory) but serves as a key shareholder feedback mechanism on compensation design and governance, and the Board’s recommendation reflects their view that the program supports long-term shareholder value.
Approve amendment to Article 4(A) of the Articles of Incorporation to increase authorized common stock from 20,000,000 to 40,000,000 shares.
This management proposal requests shareholder approval to amend Article 4(A) of ACNB’s Articles to increase authorized common shares from 20 million to 40 million. Management frames the change as prudential — giving the Board flexibility to issue shares for capital raises, acquisitions (including integration of Traditions Bancorp), employee compensation plans, stock dividends or splits, and other corporate actions without needing a special shareholder meeting. The Board discloses it has no present definitive plans to issue the additional shares, but notes future issuances could dilute existing holders and that the amendment is not intended as an anti-takeover device (while acknowledging additional shares could have the incidental effect of making certain transactions more difficult). From a governance perspective, the increase broadens the Board’s discretion to issue stock without further shareholder approval, which could be used both for legitimate corporate finance and for opportunistic recapitalizations; therefore, analysts should assess the Board’s historical use of authorized but unissued shares, the company’s capital planning, outstanding share reserves (including ~881,149 shares already reserved for equity plans), and any shareholder protections such as rights plans or preemptive rights. The Board’s recommendation balances operational flexibility against dilution risk; sophisticated investors should seek clarity on potential near-term uses (e.g., equity compensation, deposit insurance capital, acquisition currency) and consider whether limits or pre-commitments (such as shareholder approval for certain issuance classes or size thresholds) would mitigate governance concerns. Given ACNB’s regional banking profile and recent acquisition activity, increasing authorization is consistent with strategic growth options, but prudent oversight and disclosure of any future issuances will be important to preserve shareholder value. Overall, the proposal asks for a straightforward technical amendment with significant practical implications regarding management’s ability to act quickly in capital markets.
Approve addition of Article 13 to permit the Board to authorize issuance of uncertificated (book-entry) shares for any class or series of the Corporation’s stock.
This management proposal seeks shareholder approval to add Article 13 to ACNB’s Articles, authorizing the Board to issue uncertificated (book-entry) shares for any class or series. The stated rationale is operational modernization: allowing book-entry shares simplifies recordkeeping, reduces costs and administrative burdens (including handling of lost certificates), and aligns legal authorization with the company’s Bylaws and common industry practice and exchange requirements. For shareholders, the change is largely administrative and does not alter substantive ownership rights, but it enables the Company to issue shares in electronic form and default to book-entry records, which can enhance operational efficiency and reduce friction for employees and investors. Analysts should verify that the amendment preserves shareholder protections and that the Corporation will continue to offer certificated shares on request, as management indicates, and should review how the change interacts with transfer agent practices and any jurisdictional legal nuances. The Board recommends FOR, emphasizing convenience and cost savings; the practical governance risk is low, but investors should confirm that this amendment will not be used to alter shareholder notification or transfer processes in ways that could hinder shareholder rights. Overall, the amendment is a standard corporate housekeeping update to enable modern securities practices.
Approve adoption and ratification of the ACNB Corporation Employee Stock Purchase Plan (ESPP), which reserves 300,000 shares for eligible employees to purchase with payroll deductions under Section 423 of the Code.
This management proposal requests shareholder approval to adopt and ratify ACNB’s Employee Stock Purchase Plan (ESPP), which reserves 300,000 shares for eligible employees to purchase through payroll deductions in offering periods (initially six-month offerings) at a discounted purchase price (initially up to 10% discount; Plan allows up to 15%). Management positions the Plan as a broad-based retention and alignment tool intended to incentivize employees to build ownership stakes and support long-term shareholder value. Key plan mechanics: eligibility after 30 days and customary employment >5 months/year, per-participant limits to avoid >5% ownership and a $25,000 per-year value cap, automatic payroll deductions (1–15%), pro rata allocation if oversubscribed, and standard Section 423 tax treatment for qualifying dispositions. The committee (Compensation Committee) administers the plan and retains discretion over offering periods, discounts, and custodial arrangements; shares may be newly issued, treasury, or acquired otherwise, and the company will file an S-8 if the Plan is approved. From a governance and dilution perspective, analysts should evaluate the 300,000-share reserve relative to total outstanding shares (~10.35M) and existing equity plan reserves (~881k reserved previously) to quantify potential dilution; also assess whether issuance will be used primarily for broad employee participation versus targeted grants to management. The Board’s recommendation FOR reflects a belief that the ESPP is standard market practice for employee alignment; sophisticated investors should weigh the modest dilution against expected benefits in retention and employee alignment and monitor actual participation, pricing, and any future replenishments or repricings that may materially affect shareholder value.
Ratify the selection of Crowe LLP as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
To transact any other business that may properly come before the 2026 Annual Meeting and any adjournment or postponement thereof; a placeholder for unforeseen matters properly raised at the meeting.
This is a procedural placeholder matter included in the notice that allows the proxies to vote on any other business properly brought before the meeting. It carries no substantive proposal text and is typically exercised in accordance with the Board’s judgment. Analysts should treat it as non-actionable unless a specific item is later proposed and disclosed.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 4.19% | 427,657 | $20M |
| 2 | Private Capital Management, LLC | 3.52% | 359,742 | $17M |
| 3 | BlackRock, Inc. | 3.50% | 357,137 | $17M |
| 4 | DIMENSIONAL FUND ADVISORS LP | 3.14% | 320,859 | $15M |
| 5 | FMR LLC | 2.64% | 269,315 | $13M |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.05% | 209,614 | $10M |
| 7 | STATE STREET CORP | 1.92% | 195,578 | $9M |
| 8 | AMERICAN CENTURY COMPANIES INC | 1.80% | 183,620 | $9M |
| 9 | BlackRock, Inc. | 1.78% | 181,722 | $9M |
| 10 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.60% | 162,978 | $8M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.